Literature DB >> 23366431

On the design and evaluation of the PDA-based research platform for electric and acoustic stimulation.

Hussnain Ali1, Arthur P Lobo, Philipos C Loizou.   

Abstract

The aim of the paper is to describe the bimodal (combining electrical stimulation via the implant with acoustic stimulation via hearing aids) design of the PDA-based research platform and present results from a short-term evaluation with five bimodal cochlear implant users. The evolution of the PDA platform has been reported earlier in terms of development and its potential in various experiments. This paper focuses on the evaluation of the platform with bimodal users in terms of speech intelligibility in quiet, 10dB and 5dB SNR conditions and compares the results with the users' own clinical processor. The results of this clinical trial will encourage researchers in this area to use the platform in their future studies as it provides unparalleled flexibility along with a large suite of applications to conduct a wide variety of experiments for electric-only and combined electric and acoustic stimulation (EAS) for long-term chronic studies with great ease.

Mesh:

Year:  2012        PMID: 23366431     DOI: 10.1109/EMBC.2012.6346470

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  CCi-MOBILE: A Portable Real Time Speech Processing Platform for Cochlear Implant and Hearing Research.

Authors:  Ria Ghosh; Hussnain Ali; John H L Hansen
Journal:  IEEE Trans Biomed Eng       Date:  2022-02-18       Impact factor: 4.538

2.  Design and evaluation of a personal digital assistant-based research platform for cochlear implants.

Authors:  Hussnain Ali; Arthur P Lobo; Philipos C Loizou
Journal:  IEEE Trans Biomed Eng       Date:  2013-05-13       Impact factor: 4.538

3.  Development of a real time sparse non-negative matrix factorization module for cochlear implants by using xPC target.

Authors:  Hongmei Hu; Agamemnon Krasoulis; Mark Lutman; Stefan Bleeck
Journal:  Sensors (Basel)       Date:  2013-10-14       Impact factor: 3.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.